The effects of cognitive behavioural therapy on depression and quality of life in patients with maintenance haemodialysis: a systematic review

• Published in: BMC psychiatry 2020-07, Vol.20 (1), p.369-369, Article 369
• Main Authors: Ling, Chen, Evans, Debra, Zhang, Yunfang, Luo, Jianying, Hu, Yanping, Ouyang, Yuxia, Tang, Jiamin, Kuang, Ziqiao
• Format: Article
• Language: English
• Subjects: Behavior modification; Chronic illnesses; Clinical trials; Cognition & reasoning; Cognitive ability; Cognitive Behavioral Therapy; Cognitive behavioural therapy; Cognitive therapy; Comorbidity; Depression; Depression - therapy; Haemodialysis; Hemodialysis; Humans; Maintenance; Mental depression; Psychiatry; Quality of Life; Renal Dialysis; Sertraline; Systematic review
• ISSN: 1471-244X; 1471-244X
• DOI: 10.1186/s12888-020-02754-2

Depression is highly prevalent among Haemodialysis (HD) patients and is known to results in a series of adverse outcomes and poor quality of life (QoL). Although cognitive behavioural therapy (CBT) has been shown to improve depressive symptoms and QoL in other chronic illness, there is uncertainty in terms of the effectiveness of CBT in HD patients with depression or depressive symptoms. All randomised controlled trials relevant to the topic were retrieved from the following databases: CINHAL, MEDLINE, PubMed, PsycINFO and CENTRAL. The grey literature, specific journals, reference lists of included studies and trials registers website were also searched. Data was extracted or calculated from included studies that had measured depression and quality of life using valid and reliable tools -this included mean differences or standardised mean differences and 95% confidence intervals. The Cochrane risk of bias tool was used to identify the methodological quality of the included studies. Six RCTs were included with varying methodological quality. Meta-analysis was undertaken for 3 studies that employed the CBT versus usual care. All studies showed that the depressive symptoms significantly improved after the CBT. Furthermore, CBT was more effective than usual care (MD = - 5.28, 95%CI - 7.9 to - 2.65, P = 0.37) and counselling (MD = - 2.39, 95%CI - 3.49 to - 1.29), while less effective than sertraline (MD = 2.2, 95%CI 0.43 to 3.97) in alleviating depressive symptoms. Additionally, the CBT seems to have a beneficial effect in improving QoL when compared with usual care, while no significant difference was found in QoL score when compared CBT with sertraline. CBT may improve depressive symptoms and QoL in HD patients with comorbid depressive symptoms. However, more rigorous studies are needed in this field due to the small quantity and varied methodological quality in the identified studies.